CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Amerisource Health Services LLC recalls Meclizine Hydrochloride Tablets

Read the official FDA notice

Published
1 Apr 2026
Units affected
697 cartons
Agency
FDA
Country
United States

The hazard

Failed tablet specifications.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.

Brand / company
Amerisource Health Services LLC
Codes / lots
Lot #1024852; Exp 9/30/2026
Distribution
U.S. Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 1 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.